HIV-1 eradication strategies: Design and assessment

Research output: Contribution to journalArticle

Abstract

PURPOSE OF REVIEW: Recent developments have generated renewed interest in the possibility of curing HIV-1 infection. This review describes some of the practical challenges that will need to be overcome if curative strategies are to be successful. RECENT FINDINGS: The latent reservoir for HIV-1 in resting memory CD4 T cells is the major barrier to curing the infection. The most widely discussed approach to curing the infection involves finding agents that reverse latency in resting CD4 T cells, with the assumption that the cells will then die from viral cytopathic effects or be lysed by host cytolytic T lymphocytes (CTLs). A major challenge is the development of in-vitro models that can be used to explore mechanisms and identify latency-reversing agents (LRAs). Although several models have been developed, including primary cell models, none of them may fully capture the quiescent state of the cells that harbour latent HIV-1 in vivo. An additional problem is that LRAs that do not cause T-cell activation may not lead to the death of infected cells. Finally, measuring the effects of LRAs in vivo is complicated by the lack of correlation between different assays for the latent reservoir. SUMMARY: Progress on these practical issues is essential to finding a cure.

Original languageEnglish (US)
Pages (from-to)318-325
Number of pages8
JournalCurrent Opinion in HIV and AIDS
Volume8
Issue number4
DOIs
StatePublished - Jul 2013

Fingerprint

HIV-1
T-Lymphocytes
Viral Cytopathogenic Effect
Infection
HIV Infections
Cell Death

Keywords

  • eradication
  • HIV latency
  • reservoir

ASJC Scopus subject areas

  • Hematology
  • Oncology(nursing)
  • Immunology
  • Infectious Diseases
  • Virology
  • Oncology

Cite this

HIV-1 eradication strategies : Design and assessment. / Siliciano, Janet M; Siliciano, Robert F.

In: Current Opinion in HIV and AIDS, Vol. 8, No. 4, 07.2013, p. 318-325.

Research output: Contribution to journalArticle

@article{f8435fb66df2424a9896526c6f8b1ba6,
title = "HIV-1 eradication strategies: Design and assessment",
abstract = "PURPOSE OF REVIEW: Recent developments have generated renewed interest in the possibility of curing HIV-1 infection. This review describes some of the practical challenges that will need to be overcome if curative strategies are to be successful. RECENT FINDINGS: The latent reservoir for HIV-1 in resting memory CD4 T cells is the major barrier to curing the infection. The most widely discussed approach to curing the infection involves finding agents that reverse latency in resting CD4 T cells, with the assumption that the cells will then die from viral cytopathic effects or be lysed by host cytolytic T lymphocytes (CTLs). A major challenge is the development of in-vitro models that can be used to explore mechanisms and identify latency-reversing agents (LRAs). Although several models have been developed, including primary cell models, none of them may fully capture the quiescent state of the cells that harbour latent HIV-1 in vivo. An additional problem is that LRAs that do not cause T-cell activation may not lead to the death of infected cells. Finally, measuring the effects of LRAs in vivo is complicated by the lack of correlation between different assays for the latent reservoir. SUMMARY: Progress on these practical issues is essential to finding a cure.",
keywords = "eradication, HIV latency, reservoir",
author = "Siliciano, {Janet M} and Siliciano, {Robert F}",
year = "2013",
month = "7",
doi = "10.1097/COH.0b013e328361eaca",
language = "English (US)",
volume = "8",
pages = "318--325",
journal = "Current Opinion in HIV and AIDS",
issn = "1746-630X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - HIV-1 eradication strategies

T2 - Design and assessment

AU - Siliciano, Janet M

AU - Siliciano, Robert F

PY - 2013/7

Y1 - 2013/7

N2 - PURPOSE OF REVIEW: Recent developments have generated renewed interest in the possibility of curing HIV-1 infection. This review describes some of the practical challenges that will need to be overcome if curative strategies are to be successful. RECENT FINDINGS: The latent reservoir for HIV-1 in resting memory CD4 T cells is the major barrier to curing the infection. The most widely discussed approach to curing the infection involves finding agents that reverse latency in resting CD4 T cells, with the assumption that the cells will then die from viral cytopathic effects or be lysed by host cytolytic T lymphocytes (CTLs). A major challenge is the development of in-vitro models that can be used to explore mechanisms and identify latency-reversing agents (LRAs). Although several models have been developed, including primary cell models, none of them may fully capture the quiescent state of the cells that harbour latent HIV-1 in vivo. An additional problem is that LRAs that do not cause T-cell activation may not lead to the death of infected cells. Finally, measuring the effects of LRAs in vivo is complicated by the lack of correlation between different assays for the latent reservoir. SUMMARY: Progress on these practical issues is essential to finding a cure.

AB - PURPOSE OF REVIEW: Recent developments have generated renewed interest in the possibility of curing HIV-1 infection. This review describes some of the practical challenges that will need to be overcome if curative strategies are to be successful. RECENT FINDINGS: The latent reservoir for HIV-1 in resting memory CD4 T cells is the major barrier to curing the infection. The most widely discussed approach to curing the infection involves finding agents that reverse latency in resting CD4 T cells, with the assumption that the cells will then die from viral cytopathic effects or be lysed by host cytolytic T lymphocytes (CTLs). A major challenge is the development of in-vitro models that can be used to explore mechanisms and identify latency-reversing agents (LRAs). Although several models have been developed, including primary cell models, none of them may fully capture the quiescent state of the cells that harbour latent HIV-1 in vivo. An additional problem is that LRAs that do not cause T-cell activation may not lead to the death of infected cells. Finally, measuring the effects of LRAs in vivo is complicated by the lack of correlation between different assays for the latent reservoir. SUMMARY: Progress on these practical issues is essential to finding a cure.

KW - eradication

KW - HIV latency

KW - reservoir

UR - http://www.scopus.com/inward/record.url?scp=84880330155&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880330155&partnerID=8YFLogxK

U2 - 10.1097/COH.0b013e328361eaca

DO - 10.1097/COH.0b013e328361eaca

M3 - Article

C2 - 23698561

AN - SCOPUS:84880330155

VL - 8

SP - 318

EP - 325

JO - Current Opinion in HIV and AIDS

JF - Current Opinion in HIV and AIDS

SN - 1746-630X

IS - 4

ER -